Request for Information (RFI) on the Future Directions of Lupus Research
Notice NOT-AR-15-007 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 17, 2014 Category: Research Source Type: funding

Call for Nominations: Lupus Foundation of America Evelyn V. Hess Award
Deadline: Friday, June 27, 2014 In recognition of her outstanding contributions to lupus research over the course of her long career, the Lupus Foundation of America, Inc. established the Evelyn V. Hess Award, given annually to a clinical or basic researcher whose body of work has advanced understanding of the pathophysiology, etiology, epidemiology, diagnosis, or treatment of lupus. Candidates for this award must meet the following criteria: -- Have a MD or PhD. -- Have a career of achievement in basic or clinical research in lupus. -- Have an academic appointment at the level of Associate Pr...
Source: ScanGrants feed - June 23, 2014 Category: Research Authors: Lupus Foundation of America Source Type: funding

Call for Nominations: Lupus Foundation of America Mary Betty Stevens, MD, Young Investigator Prize
Deadline: 5:00 PM EST on Friday, June 27, 2014 The Mary Betty Stevens, MD, Young Investigator prize, supported by the Lupus Foundation of America, Inc., recognizes the exceptional achievements of an investigator in the early part of his or her independent career in lupus research. Candidates for this award must meet the following criteria: -- Must be a licensed physician. -- Must be nominated by a peer. -- Must be ten or fewer years out from the first full-time faculty appointment or equivalent, in an academic or clinical research setting, and have a current designation as either an Assistant or As...
Source: ScanGrants feed - June 23, 2014 Category: Research Authors: Lupus Foundation of America Source Type: funding

Call for Applications: Target Identification in Lupus
Letter of intent due date: July 10, 2014 Application due date: August 25, 2014 The Alliance for Lupus Research (ALR) is pleased to announce that the applications for the ALR’s Target Identification in Lupus (TIL) grants are now available online.  The guidelines and application are also available through the Altum proposalCENTRAL website at https://proposalcentral.altum.com. Funding for the TIL award will be made for up to $200,000 per year (for a maximum of three years - total amount up to $600,000) including indirect costs. Funding for the third year is based on the successful submission of a n...
Source: ScanGrants feed - June 5, 2014 Category: Research Authors: Alliance for Lupus Research Source Type: funding

Call for Applications: Lupus Research Institute Novel Research Grants
Grant Application Deadline:  August 4, 2014 The Lupus Research Institute (LRI) invites applications for financial support for idea-driven, novel research projects relevant to basic, translational or clinical investigation in lupus. Novel Research Grants provide early stage support for exceptionally creative and innovative approaches to major challenges in lupus research. Successful proposals will advance novel hypotheses and/or technologies that have the potential to stimulate new research directions and propel the field forward. Applications will be judged principally on novelty of the hypotheses, scient...
Source: ScanGrants feed - May 19, 2014 Category: Research Authors: Lupus Research Institute Source Type: funding

Request for Applications: Clinical and Translational Pediatric Lupus Nephritis Biomarker Panel Research
Award Amount: $500,000 ($100,000 per year for five years) Letter of Intent Deadline: May 30, 2014 at 5 p.m. EST Application Deadline: June 30, 2014 at 5 p.m. EST Earliest Award Date: September 5, 2014 On behalf of the Michael Jon Barlin Pediatric Research Program, the Lupus Foundation of America issues this request for application (RFA) to address a critical need in pediatric lupus nephritis. Lupus nephritis is one of the most severe and pervasive organ manifestations of lupus, affecting up to 80% of children and adolescents with lupus. Up to 40% of children with lupus nephritis may progress to end...
Source: ScanGrants feed - May 19, 2014 Category: Research Authors: Lupus Foundation of America, Inc. Source Type: funding

Call for Applications: Lupus Research Institute Distinguished Innovator Awards
Grant Application Deadline: July 31, 2014 The Lupus Research Institute (LRI) invites applications for its Distinguished Innovator Awards, a global program that will provide outstanding scientists with substantial support for up to four years to conduct novel research into the fundamental causes of lupus and so provide new directions toward a cure or prevention. Advances across many disciplines have led to novel treatments that aim to suppress the manifestations of lupus. Yet few interventions are being developed that seek to reverse or prevent the disease. LRI Distinguished Innovators will address this gap by ...
Source: ScanGrants feed - May 1, 2014 Category: Research Authors: Lupus Research Institute Source Type: funding

FY14 National Health Education Program on Lupus for Healthcare Providers
Funding Opportunity Number: MP-CPI-14-001 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.137Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-OPHSClosing Date: Jun 09, 2014Award Ceiling: $2,000,000Expected Number of Awards: 1Creation Date: Apr 16, 2014Funding Opportunity Description: The purpose of the NHEPLHP is to eliminate lupus related health disparities among racial and ethnic minority populations disproportionately affected by this...
Source: Grants.gov - April 17, 2014 Category: Research Tags: Health Source Type: funding

Notice of Pre-Application Webinar for RFA-AR-14-015 and RFA-AR-14-016 "Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus"
Notice NOT-AR-14-019 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 2, 2014 Category: Research Source Type: funding

Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Leadership Center (UM2)
Funding Opportunity Number: RFA-AR-14-015 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.84693.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a...
Source: Grants.gov - March 21, 2014 Category: Research Tags: Health Source Type: funding

Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Research Sites (UH2/UH3)
Funding Opportunity Number: RFA-AR-14-016 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.84693.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a...
Source: Grants.gov - March 21, 2014 Category: Research Tags: Health Source Type: funding

Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Leadership Center (UM2)
Funding Opportunity RFA-AR-14-015 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for the Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis (RA) and Lupus Network Leadership Center. The AMP RA and Lupus Network is designed to ascertain and define shared and disease-specific biological pathways in order to identify relevant drug targets for the treatment of autoimmune diseases. This program will involve an enhanced systems-level understanding of gene expression and signaling in target tissues from affected end organs and peripheral blood cells. (Source: NI...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 21, 2014 Category: Research Source Type: funding

Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Research Sites (UH2/UH3)
Funding Opportunity RFA-AR-14-016 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for the Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis (RA) and Lupus Network Research Sites. The AMP RA and Lupus Network is designed to ascertain and define shared and disease-specific biological pathways in order to identify relevant drug targets for the treatment of autoimmune diseases. This program will involve an enhanced systems-level understanding of gene expression and signaling in target tissues from affected end organs and peripheral blood cells. (Source: NIH F...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 21, 2014 Category: Research Source Type: funding

Call for Applications: 2014 Gina M. Finzi Memorial Student Summer Fellowship Program
Application Deadline: March 28, 2014 at 5 PM ET Purpose: To foster an interest, among students, in the areas of basic, clinical, translational, epidemiological, or behavioral research relevant to lupus under the sponsorship and supervision of an established, tenure-track Principal Investigator who directs a laboratory, dedicated at least in part to the investigation of lupus at an academic, medical, or research institution in the U.S., Canada, or Mexico. Fellowship Award Amount: $4,000 ELIGIBILITY Although undergraduate students may apply, preference will be given to graduate or medical students wh...
Source: ScanGrants feed - February 25, 2014 Category: Research Authors: Lupus Foundation of America, Inc. Source Type: funding

Call for Applications: Lupus Foundation of America 2014 Career Development Award
Application Deadline: March 28, 2014 at 5 p.m. ET Purpose: To facilitate the professional development of heumatology, nephrology, and dermatology fellows, in the U.S. and Canada, interested in lupus research to wards a career as an independent clinician-scientist at an academic, medical, or research institution, with a research program having considerable focus on the investigation of basic, clinical, translational, behavioral, or epidemiological lupus research. Award Amount: $70,000 per year (for a maximum of 2 years) ELIGIBILITY To be eligible to apply, applicants must hold an M.D. (or equivalent...
Source: ScanGrants feed - February 25, 2014 Category: Research Authors: Lupus Foundation of America, Inc. Source Type: funding